Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,423 | 30,154 | 18,413 | 42,056 | 18,771 |
| Marketable Securities | N/A | 24,929 | 59,541 | 57,150 | 104,284 |
| Receivables | 27,778 | N/A | N/A | N/A | N/A |
| Other current assets | 3,926 | 4,546 | 4,908 | 4,229 | 4,889 |
| TOTAL | $62,127 | $59,629 | $82,862 | $103,435 | $127,944 |
| Non-Current Assets | |||||
| PPE Net | 1,334 | 1,590 | 1,867 | 2,035 | 2,063 |
| Other Non-Current Assets | 2,866 | 3,339 | 3,804 | 4,294 | 4,699 |
| TOTAL | $4,200 | $4,929 | $5,671 | $6,329 | $6,762 |
| Total Assets | $66,327 | $64,558 | $88,533 | $109,764 | $134,706 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,431 | 7,639 | 3,982 | 4,651 | 3,937 |
| Accrued Expenses | 18,696 | 11,989 | 13,526 | 13,605 | 12,209 |
| TOTAL | $28,343 | $23,322 | $21,233 | $21,987 | $20,265 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 168 | 579 |
| Other Non-Current Liabilities | 6,100 | 9,447 | 13,755 | 15,822 | 12,453 |
| TOTAL | $6,100 | $9,447 | $13,755 | $15,944 | $12,575 |
| Total Liabilities | $34,443 | $32,769 | $34,988 | $37,931 | $32,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,245 | 6,188 | 6,188 | 6,154 | 6,151 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -666,745 | -665,241 | -642,201 | -622,320 | -590,783 |
| Other shareholders' equity | 437 | 438 | 468 | 455 | 420 |
| TOTAL | $31,884 | $31,789 | $53,545 | $71,833 | $101,866 |
| Total Liabilities And Equity | $66,327 | $64,558 | $88,533 | $109,764 | $134,706 |